Intexa SA (EPA:ITXT)
2.500
0.00 (0.00%)
At close: Aug 12, 2025
Orchard Therapeutics Revenue
In the year 2024, Intexa had annual revenue of 281.00K EUR, down -5.39%. Intexa had revenue of 138.00K in the half year ending December 31, 2024, a decrease of -4.83%.
Revenue
281.00K
Revenue Growth
-5.39%
P/S Ratio
9.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 281.00K | -16.00K | -5.39% |
Dec 31, 2023 | 297.00K | 10.00K | 3.48% |
Dec 31, 2022 | 287.00K | 16.00K | 5.90% |
Dec 31, 2021 | 271.00K | -9.00K | -3.21% |
Dec 31, 2020 | 280.00K | -1.00K | -0.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
LVMH Moët Hennessy - Louis Vuitton, Société Européenne | 82.82B |
Hermès International Société en commandite par actions | 15.70B |
Christian Dior SE | 82.82B |
Kering | 15.76B |
Compagnie Générale des Établissements Michelin Société en commandite par actions | 26.74B |
Accor | 5.67B |
Renault | 56.91B |
FDJ United | 3.50B |